FI972313L - Uusia 2,3-diketopiperatsiinijohdannaisia ja niiden suoloja - Google Patents
Uusia 2,3-diketopiperatsiinijohdannaisia ja niiden suoloja Download PDFInfo
- Publication number
- FI972313L FI972313L FI972313A FI972313A FI972313L FI 972313 L FI972313 L FI 972313L FI 972313 A FI972313 A FI 972313A FI 972313 A FI972313 A FI 972313A FI 972313 L FI972313 L FI 972313L
- Authority
- FI
- Finland
- Prior art keywords
- salts
- new
- diketopiperazine derivatives
- diketopiperazine
- derivatives
- Prior art date
Links
- JTHRRMFZHSDGNJ-UHFFFAOYSA-N piperazine-2,3-dione Chemical class O=C1NCCNC1=O JTHRRMFZHSDGNJ-UHFFFAOYSA-N 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
- C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP32381394 | 1994-12-01 | ||
| JP33688494 | 1994-12-27 | ||
| JP33688394 | 1994-12-27 | ||
| PCT/JP1995/002391 WO1996016947A1 (fr) | 1994-12-01 | 1995-11-24 | Nouveau derive de 2,3-dicetopiperazine ou sel de celui-ci |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI972313A0 FI972313A0 (fi) | 1997-05-30 |
| FI972313L true FI972313L (fi) | 1997-07-30 |
Family
ID=27340008
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI972313A FI972313L (fi) | 1994-12-01 | 1997-05-30 | Uusia 2,3-diketopiperatsiinijohdannaisia ja niiden suoloja |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US5877174A (fi) |
| EP (1) | EP0805149A4 (fi) |
| CN (1) | CN1170409A (fi) |
| AU (1) | AU691361B2 (fi) |
| CA (1) | CA2206053A1 (fi) |
| FI (1) | FI972313L (fi) |
| HU (1) | HUT77309A (fi) |
| NO (1) | NO308660B1 (fi) |
| TW (1) | TW346486B (fi) |
| WO (1) | WO1996016947A1 (fi) |
Families Citing this family (68)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996016947A1 (fr) * | 1994-12-01 | 1996-06-06 | Toyama Chemical Co., Ltd. | Nouveau derive de 2,3-dicetopiperazine ou sel de celui-ci |
| DE69608359T2 (de) * | 1995-02-01 | 2001-02-08 | Asahi Kasei Kogyo K.K., Osaka | Hexaazaisowurtzitan-derivate und verfahren zu deren herstellung |
| US6428771B1 (en) * | 1995-05-15 | 2002-08-06 | Pharmaceutical Discovery Corporation | Method for drug delivery to the pulmonary system |
| EP0986551B1 (en) | 1997-05-30 | 2006-08-02 | Takeda Pharmaceutical Company Limited | Sulfonamide derivatives, their production and use |
| KR20010034442A (ko) * | 1998-01-27 | 2001-04-25 | 아벤티스 파마슈티칼즈 프로덕츠 인코포레이티드 | 치환된 옥소아자헤테로사이클릴 인자 Ｘａ 억제제 |
| US6403595B1 (en) | 1998-02-05 | 2002-06-11 | Takeda Chemical Industries, Ltd. | Sulfonamide derivatives, processes for producing the same and utilization thereof |
| DE19833105A1 (de) * | 1998-07-23 | 2000-01-27 | Boehringer Ingelheim Pharma | Substituierte Phenylamidine, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
| US6242466B1 (en) | 1998-07-23 | 2001-06-05 | Boehringer Ingelheim Pharma Kg | Substituted phenylamidines |
| CA2353151A1 (en) * | 1998-12-16 | 2000-06-22 | Boehringer Ingelheim Pharma Kg | Substituted aryl and heteroaryl derivatives, the preparation thereof and their use as medicaments |
| DK1808438T3 (da) * | 1999-06-29 | 2014-10-27 | Mannkind Corp | Rensning og stabilisering af peptid og proteiner i lægemidler |
| US9006175B2 (en) | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
| PT1311269E (pt) | 2000-08-04 | 2012-05-10 | Dmi Biosciences Inc | Método de utilização de dicetopiperazinas e composição que contém as mesmas |
| DK1481966T3 (da) | 2002-03-06 | 2011-10-24 | Toyama Chemical Co Ltd | Nyt arylamidinderivat eller salt deraf |
| AU2003220125B2 (en) | 2002-03-20 | 2006-06-15 | Mannkind Corporation | Inhalation apparatus |
| EP1545457A4 (en) | 2002-08-01 | 2009-07-01 | Mannkind Corp | CELL TRANSPORT COMPOSITIONS AND ITS USES |
| US20080260838A1 (en) * | 2003-08-01 | 2008-10-23 | Mannkind Corporation | Glucagon-like peptide 1 (glp-1) pharmaceutical formulations |
| US20040038865A1 (en) * | 2002-08-01 | 2004-02-26 | Mannkind Corporation | Cell transport compositions and uses thereof |
| ATE520981T1 (de) * | 2002-10-02 | 2011-09-15 | Dmi Biosciences Inc | Diagnose und überwachung von krankheiten |
| US20040224024A1 (en) * | 2003-04-23 | 2004-11-11 | Massachusetts Institute Of Technology | Controlled drug release formulations containing polyion complexes |
| KR20170038128A (ko) | 2003-05-15 | 2017-04-05 | 앰피오 파마슈티컬스 인코퍼레이티드 | Ｔ-세포 매개성 질환의 치료 방법 |
| US7338171B2 (en) * | 2003-10-27 | 2008-03-04 | Jen-Chuen Hsieh | Method and apparatus for visual drive control |
| CA2552707C (en) * | 2004-01-12 | 2018-03-27 | Mannkind Corporation | A method of reducing serum proinsulin levels in type 2 diabetics |
| US7279457B2 (en) * | 2004-03-12 | 2007-10-09 | Biodel, Inc. | Rapid acting drug delivery compositions |
| US20080248999A1 (en) * | 2007-04-04 | 2008-10-09 | Biodel Inc. | Amylin formulations |
| US20080090753A1 (en) * | 2004-03-12 | 2008-04-17 | Biodel, Inc. | Rapid Acting Injectable Insulin Compositions |
| DE602005024413D1 (de) | 2004-08-20 | 2010-12-09 | Mannkind Corp | Katalyse der diketopiperazinsynthese |
| EP2322180B1 (en) | 2004-08-23 | 2015-05-27 | MannKind Corporation | Diketopiperazine salts for drug delivery |
| CN102614131A (zh) | 2005-09-14 | 2012-08-01 | 曼金德公司 | 以提高结晶微粒表面对活性试剂的亲和力为基础的药物配制方法 |
| US20070086952A1 (en) * | 2005-09-29 | 2007-04-19 | Biodel, Inc. | Rapid Acting and Prolonged Acting Inhalable Insulin Preparations |
| US7713929B2 (en) | 2006-04-12 | 2010-05-11 | Biodel Inc. | Rapid acting and long acting insulin combination formulations |
| US8084420B2 (en) * | 2005-09-29 | 2011-12-27 | Biodel Inc. | Rapid acting and long acting insulin combination formulations |
| JP5038155B2 (ja) | 2005-12-29 | 2012-10-03 | 富山化学工業株式会社 | 新規なアリールアミジン誘導体およびその塩ならびにそれらを含有する抗真菌剤 |
| BRPI0707991B8 (pt) | 2006-02-22 | 2021-05-25 | Mannkind Corp | métodos de preparação de um medicamento em pó seco com uma propriedade farmacêutica melhorada, dito pó seco e uso de uma quantidade efetiva do pó seco |
| AU2007238114B2 (en) * | 2006-04-12 | 2010-10-14 | Biodel, Inc. | Rapid acting and long acting insulin combination formulations |
| CA2703234C (en) * | 2007-10-24 | 2021-10-26 | Mannkind Corporation | An inhalable dry powder formulation comprising glp-1 for use by pulmonary inhalation |
| US8785396B2 (en) | 2007-10-24 | 2014-07-22 | Mannkind Corporation | Method and composition for treating migraines |
| EP2954893A1 (en) | 2007-10-24 | 2015-12-16 | MannKind Corporation | An inhalable dry powder formulation comprising glp-1 for use in the treatment of hyperglycemia and diabetes |
| CN101951957A (zh) * | 2008-01-04 | 2011-01-19 | 百达尔公司 | 胰岛素释放作为组织的葡萄糖水平的函数的胰岛素制剂 |
| WO2009146320A1 (en) | 2008-05-27 | 2009-12-03 | Dmi Life Sciences, Inc. | Therapeutic methods and compounds |
| US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
| IL313823A (en) | 2008-06-13 | 2024-08-01 | Mannkind Corp | A dry powder inhaler and system for drug delivery |
| AU2009259883B2 (en) | 2008-06-20 | 2015-02-05 | Mannkind Corporation | An interactive apparatus and method for real-time profiling of inhalation efforts |
| TWI494123B (zh) | 2008-08-11 | 2015-08-01 | Mannkind Corp | 超快起作用胰島素之用途 |
| US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
| US9060927B2 (en) * | 2009-03-03 | 2015-06-23 | Biodel Inc. | Insulin formulations for rapid uptake |
| CA2754595C (en) | 2009-03-11 | 2017-06-27 | Mannkind Corporation | Apparatus, system and method for measuring resistance of an inhaler |
| KR20190090092A (ko) | 2009-06-12 | 2019-07-31 | 맨카인드 코포레이션 | 한정된 비표면적을 갖는 디케토피페라진 마이크로입자 |
| EP2496295A1 (en) | 2009-11-03 | 2012-09-12 | MannKind Corporation | An apparatus and method for simulating inhalation efforts |
| KR20130117755A (ko) | 2010-06-21 | 2013-10-28 | 맨카인드 코포레이션 | 건조 분말 약물 운반 시스템 및 방법 |
| US8507496B2 (en) | 2010-09-07 | 2013-08-13 | Dmi Acquisition Corp. | Treatment of diseases |
| MX353285B (es) | 2011-04-01 | 2018-01-05 | Mannkind Corp | Paquete de blister para cartuchos farmaceuticos. |
| WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
| SG10201608087WA (en) | 2011-10-10 | 2016-11-29 | Ampio Pharmaceuticals Inc | Implantable medical devices with increased immune tolerance, and methods for making and implanting |
| EA028343B1 (ru) | 2011-10-10 | 2017-11-30 | Ампио Фармасьютикалз, Инк. | Лечение дегенеративного заболевания сустава |
| BR112014009686A2 (pt) | 2011-10-24 | 2018-08-07 | Mannkind Corp | composição analgésica inalável, pó seco e método para tratar dor |
| WO2013063413A1 (en) | 2011-10-28 | 2013-05-02 | Ampio Pharmaceuticals, Inc. | Treatment of rhinitis |
| BR112015000529B1 (pt) | 2012-07-12 | 2022-01-11 | Mannkind Corporation | Inalador de pó seco |
| US10159644B2 (en) | 2012-10-26 | 2018-12-25 | Mannkind Corporation | Inhalable vaccine compositions and methods |
| KR102391750B1 (ko) | 2013-03-15 | 2022-04-28 | 맨카인드 코포레이션 | 미세결정성 디케토피페라진 조성물 및 방법 |
| SG11201506267XA (en) | 2013-03-15 | 2015-09-29 | Ampio Pharmaceuticals Inc | Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same |
| BR112016000937A8 (pt) | 2013-07-18 | 2021-06-22 | Mannkind Corp | formulações farmacêuticas de pó seco, método para a fabricação de uma formulação de pó seco e uso de uma formulação farmacêutica de pó seco |
| CA2920488C (en) | 2013-08-05 | 2022-04-26 | Mannkind Corporation | Insufflation apparatus and methods |
| JP6175145B2 (ja) * | 2013-12-10 | 2017-08-02 | 日本曹達株式会社 | アリールアミジン化合物および殺菌剤 |
| WO2015148905A1 (en) | 2014-03-28 | 2015-10-01 | Mannkind Corporation | Use of ultrarapid acting insulin |
| AU2015305611B2 (en) | 2014-08-18 | 2020-04-23 | Ampio Pharmaceuticals, Inc. | Treatment of joint conditions |
| US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
| EP3310375A4 (en) | 2015-06-22 | 2019-02-20 | Ampio Pharmaceuticals, Inc. | USE OF LOW-MOLECULAR FRACTIONS OF HUMAN SERUMALBUMINE IN THE TREATMENT OF ILLNESSES |
| US11260040B2 (en) | 2018-06-15 | 2022-03-01 | Ecolab Usa Inc. | On site generated performic acid compositions for teat treatment |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2019820A1 (de) * | 1970-04-23 | 1971-11-18 | Yoshitomi Pharmaceutical | Heterocyclische Verbindungen und Verfahren zu deren Herstellung |
| JP2556722B2 (ja) * | 1988-02-18 | 1996-11-20 | 興和株式会社 | 新規なスルホンアミド化合物 |
| CN1134695A (zh) * | 1994-07-15 | 1996-10-30 | 明治制果株式会社 | 具有血小板凝聚抑制作用的新颖化合物 |
| WO1996016947A1 (fr) * | 1994-12-01 | 1996-06-06 | Toyama Chemical Co., Ltd. | Nouveau derive de 2,3-dicetopiperazine ou sel de celui-ci |
| DE19515500A1 (de) * | 1995-04-27 | 1996-10-31 | Thomae Gmbh Dr K | Substituierte Phenylamidine, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
-
1995
- 1995-11-24 WO PCT/JP1995/002391 patent/WO1996016947A1/ja not_active Application Discontinuation
- 1995-11-24 US US08/849,074 patent/US5877174A/en not_active Expired - Fee Related
- 1995-11-24 HU HU9701812A patent/HUT77309A/hu unknown
- 1995-11-24 CN CN95196903A patent/CN1170409A/zh active Pending
- 1995-11-24 CA CA002206053A patent/CA2206053A1/en not_active Abandoned
- 1995-11-24 AU AU39360/95A patent/AU691361B2/en not_active Ceased
- 1995-11-24 EP EP95937174A patent/EP0805149A4/en not_active Withdrawn
- 1995-11-29 TW TW084112700A patent/TW346486B/zh active
-
1997
- 1997-05-30 FI FI972313A patent/FI972313L/fi unknown
- 1997-05-30 NO NO972488A patent/NO308660B1/no not_active IP Right Cessation
-
1998
- 1998-10-29 US US09/182,011 patent/US6153613A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0805149A1 (en) | 1997-11-05 |
| TW346486B (en) | 1998-12-01 |
| CN1170409A (zh) | 1998-01-14 |
| AU3936095A (en) | 1996-06-19 |
| HUT77309A (hu) | 1998-03-30 |
| AU691361B2 (en) | 1998-05-14 |
| WO1996016947A1 (fr) | 1996-06-06 |
| CA2206053A1 (en) | 1996-06-06 |
| FI972313A0 (fi) | 1997-05-30 |
| US6153613A (en) | 2000-11-28 |
| NO308660B1 (no) | 2000-10-09 |
| NO972488L (no) | 1997-07-30 |
| US5877174A (en) | 1999-03-02 |
| NO972488D0 (no) | 1997-05-30 |
| EP0805149A4 (en) | 1998-03-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI972313L (fi) | Uusia 2,3-diketopiperatsiinijohdannaisia ja niiden suoloja | |
| FI955235L (fi) | Oksatsolidiinionijohdannaiset, niiden valmistus ja käyttö | |
| FI954829L (fi) | Aroyylipiperidiinijohdannaiset | |
| NO952854D0 (no) | 1-arylpyrimidin-derivater | |
| DE59508427D1 (de) | 3-aryl-4-hydroxy-delta 3 -dihydrothiophenon-derivate | |
| FI971529L (fi) | Uudet karboksyylihappojohdannaiset, niiden valmistus ja käyttö | |
| TR199501209A2 (tr) | Urea türevleri | |
| FI945281L (fi) | Heterosykliset yhdisteet, niiden valmistus ja käyttö | |
| FI952424L (fi) | 11,21-bisfenyyli-19-norpregaanijohdannaisia | |
| EP0708091A3 (en) | Indoloyl-guanidines derivatives | |
| FI954255A0 (fi) | 2,9-diamino- ja 2-amino-8-karbaomyyli-4-hydroksi-alkaanihappoamidijohdannaiset | |
| DE59507222D1 (de) | Substituierte 1,2,3,4-tetrahydro-5-nitro-pyrimidine | |
| EE200100347A (et) | 3,3-biarüülpiperidiini ja 2,2-biarüülmorfoliini derivaadid | |
| DE69430587D1 (de) | Pyrimidin-acyclonukleosid-derivate | |
| FI971227L (fi) | Pyramidinyylipyratsolijohdannaisia | |
| FI972306A0 (fi) | Substituoituja 2-aryylikarbonyylioksimetyyli-1,2,5-tiadiatsolidin -3- oni-1,1-dioksidi-johdannaisia ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi | |
| IS4321A (is) | Nýjar díalkoxý-pýridínýl-bensimidasólafleiður | |
| FI954229L (fi) | Heterosykliset yhdisteet, niiden käyttö ja valmistus | |
| FI955679A0 (fi) | Piperidiinijohdannaisia, niiden valmistus ja käyttö | |
| FI953956L (fi) | 2,3-rengaskondensoidut 1,4-dihydropyridiinit, menetelmät niiden valmistamiseksi ja niiden käyttö lääkkeinä | |
| DE69527786D1 (de) | Diaminomethyliden-derivate | |
| FI964853L (fi) | Deasetoksitaksolijohdannaiset | |
| DE69714358D1 (de) | 9,10-disubstituierte campothecinderivate mit antitumoraktivität | |
| FI953269L (fi) | Synteettiset peptidijohdannaiset ja niiden suolat | |
| FI971317A (fi) | Uusia heterosyklisiä, substituoituja imidatsolokinoksalinoneja, niiden valmistus ja käyttö |